Notification and current-status evidence
The sent-report ledger records the first outgoing report at . A report was sent to the recorded registrar; contact details remain in Domain Intelligence. The latest stored availability evidence still shows the domain reachable; 5 months has elapsed since the first outgoing report.
ICANN RAA §3.18 describes registrar abuse-contact and handling obligations. This section records outgoing timestamps and later availability. It does not by itself prove receipt, acknowledgement, investigation, remediation, or contractual non-compliance.
purepharmas[.]com
“Research-Grade Peptides”
证据摘要
The domain purepharmas.com was registered on March 11, 2026 and is hosted on IP 193.23.118.89, which belongs to ASN AS214036 (Ultahost, Inc.) and resolves to the Netherlands. The authoritative nameservers are elliott.ns.cloudflare.com and may.ns.cloudflare.com, and the site presents a valid Let’s Encrypt R13 TLS certificate. The landing page returns HTTP 200 and carries the title “Research-Grade Peptides,” suggesting a fabricated pharmaceutical front.
Infrastructure analysis shows a WordPress stack backed by MySQL, PHP, Yoast SEO, Apache HTTP Server, Underscore.js, Swiper, and reCAPTCHA. An MX record for mail.purepharmas.com is present with priority 0, indicating a functional mail subsystem. The domain’s Gridinsoft trust score is 0 / 100, and VirusTotal reports a single vendor detection out of 95 scanners. The domain appears on one external blocklist and is already listed by PhishDestroy as malicious.
Threat assessment identifies a high‑risk brand‑impersonation campaign targeting the “compound” brand, with the profile labeled as a cryptocurrency scam. The site’s content and language are crafted to lure victims into purchasing purported research‑grade peptides, likely to harvest cryptocurrency payments. While the exact payment mechanisms are not visible in the current snapshot, the presence of reCAPTCHA and a legitimate TLS certificate suggests an attempt to appear trustworthy and evade automated detection.
Defenders should immediately block purepharmas.com at DNS and proxy layers, enforce email filtering for the associated MX host, and monitor for any outbound connections to the 193.23.118.89 address. Continuous scanning of related Cloudflare‑served subdomains is advised, as is the deployment of sinkhole redirects for any future resolution attempts. Given the active status and high risk rating, organizations should also alert users about the fraudulent “Research‑Grade Peptides” offering and reinforce policies against unsolicited cryptocurrency payment requests.
已提交证据快照
- 已发送
- 台账记录
- 1
- 案件 ID
PD-20260311-F97AB5- 已捕获页面标题
- Research-Grade Peptides & High-Purity Research Compounds
- PDF 文件
- PDF 证据
法律依据
完整证据文本
Illegal Activities: Active phishing operation targeting victims
Fraud & Deception: Impersonation of legitimate services
Identity Theft: Collection of credentials under false pretenses
Applicable Laws (IS):
International Anti-Cybercrime Regulations
Budapest Convention on Cybercrime
Universal Fraud Prevention Laws
Phishing activities violate international cybercrime conventions and IS's domestic fraud laws.
Action Required: This evidence-backed report demonstrates clear violations requiring suspension per your policies. Continued hosting exposes your organization to regulatory scrutiny and potential legal liability.
Data Coverage
网络安全情报
| Detection System | Indicator | Verdict | Alert |
|---|---|---|---|
| DNS4EU | purepharmas.com |
malicious | Sinkholed |
威胁响应 Pipeline
阻止列表覆盖
监控中的外部数据源 10 个 · 已存快照 2026年8月11日
检测时间线
-
VirusTotal
0 → 1
已保存的截图
域名情报
技术详情DNS、TLS 名称和时间戳
ICANN OVERSIGHT
认证和 RAA 背景
认证和 RAA 背景
Registrar accreditation and DNS abuse obligations
For this gTLD, the registrar above operates under an ICANN accreditation agreement. The links below provide the official fee schedule and current DNS abuse compliance guidance.
Accreditation is a contract, not a safety certification.
RAA §3.18 establishes abuse-contact and handling requirements. This report can document stored outbound notices and later technical observations; it does not by itself establish receipt, investigation, remediation, or contractual non-compliance.
VirusTotal 分析
网站性能分析
Google PageSpeed Insights — mobile performance audit of purepharmas.com · checked Mar 11, 2026
您是否受到本网站的影响?
如果您输入了帐户凭据、个人或付款信息,或者从此域下载了文件,请立即采取措施。以下资源可帮助您报告事件并保护自己。
检查任意域名
使用存储的阻止列表、WHOIS、DNS 和公共扫描证据进行威胁分析
立即扫描举报网络钓鱼
将可疑域名提交至我们的威胁数据库——保护社区
报告实时威胁动态
最近的网络钓鱼报告和观察到的可用性变化
监控